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Purpose: COPD is a leading cause of morbidity and mortality. However, few studies have used 
spirometry to investigate its incidence, especially in Asia. In the present study, we analyzed the 
incidence and risk factors of COPD using a community cohort database in Korea.
Patients and methods: The study included 6,517 subjects aged 40–69 years from the 
Ansung–Ansan cohort database I–III (2001–2006). We calculated the crude incidence rate 
and the standardized incidence rate corrected for the Korean general population and the world 
population with COPD. We also determined the relative risks (RRs) for incident COPD and 
the attributable risks.
Results: In total, 329 new COPD cases were diagnosed during follow-up. The overall crude 
incidence rate per 100,000 person-years was 1,447. The standardized incidence rate corrected 
for the Korean general population was 1,550; this value was higher in men and increased with 
increasing age. Risk factors for incident COPD were age $60 years (adjusted RR [aRR] =2.52 vs 
age ,60 years), male sex (aRR =2.02 vs female), heavy smoking ($20 pack-years; aRR =2.54 
vs never smoker), and lowest income group (first quartile; aRR =2.03 vs fourth quartile). The 
adjusted attributable risk was highest for education level of high school or lower (44.9%), 
followed by smoking history (25.8%), income (22.9%), and sex (12.0%).
Conclusion: In Korea, 15.5/1,000 people are diagnosed with COPD annually. The incidence 
rate increases with increasing age, heavier smoking, and decreasing income, with a higher rate 
in men than in women.
Keywords: chronic obstructive pulmonary disease, incidence rate, relative risk, attributable risk
Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable airflow 
limitation disease that is usually progressive and associated with enhanced inflamma-
tion in the airways and lungs.1 COPD is a leading cause of chronic morbidity, mortality, 
and increased healthcare costs worldwide.2,3 It is currently the fourth leading cause 
of death globally, and the World Health Organization predicts that it will become the 
third leading cause by 2030.4
As COPD constitutes a major public health problem, precise and informative 
epidemiologic data about COPD are needed. However, reported prevalence estimates 
vary widely because of different definitions and methodologies.5 Furthermore, in 
contrast with many reports on the prevalence of COPD, there are fewer community-
based studies on the incidence of COPD.6–10 A wide range of incidence rates can be 
observed among the studies, depending on the COPD definition used and the popula-
tion studied.6–10 Despite the high burden of COPD in the Asia-Pacific region, there are 
few reports on the incidence rate of COPD in Asian countries.11
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Although cigarette smoking is the most common risk 
factor for COPD, it is not the only one, and there is consistent 
evidence from epidemiologic studies that nonsmokers may 
also develop chronic airflow limitation.12–15 Moreover, most 
of the evidence concerning risk factors for COPD comes 
from cross-sectional epidemiologic studies that identify 
associations rather than cause-and-effect relationships. Thus, 
the current understanding of risk factors for COPD is still 
incomplete in many respects.
In this study, we investigated the incidence rate of COPD 
and risk factors for incident COPD, including age, sex, 
smoking status, and income, in a Korean patient population 
from the Ansung–Ansan cohort database.
Methods
study populations
The Ansung–Ansan cohort study is an ongoing prospective 
study that was started in 2001 with support from the National 
Genome Research Institute (Korea Centers for Disease 
Control and Prevention, Cheongju, Korea). The study is 
a part of the Korean Genome and Epidemiology Study, a 
large community-based epidemiologic survey conducted to 
investigate chronic disease in Koreans. Detailed information 
on the study design and procedures has been published pre-
viously.16 Each study comprised a population-based sample 
of male and female Koreans aged 40–69 years and from the 
same ethnic background, but cohort members were enrolled 
at the following two different sites: Ansan, which is an urban 
community with a population of 555,000, and Ansung, which 
is a rural community including 133,000 residents, on the basis 
of the 2000 census. To enroll members for each cohort, the 
most efficient method was used on the basis of knowledge 
about characteristics of each community. For enrollment at 
the Ansan site, 10,957 eligible subjects were identified by 
telephone contact on the basis of a two-stage cluster-sampling 
method with the information of a governing district called 
Dong and demographic characteristics. Similarly, Ansung 
members were recruited from 5 of 11 governing districts 
called Myon by using a cluster-sampling method, and as 
a result, 7,192 eligible subjects were identified by mail or 
telephone contact and a door-to-door visit. For the baseline 
health examination from 18 June 2001 to 29 January 2003, 
5,020 participants (2,523 men and 2,497 women) from Ansan 
and 5,018 (2,239 men and 2,779 women) from Ansung visited 
the Korea University Ansan Hospital and the Ajou University 
Medical Center, respectively. In these subjects, the results of 
pulmonary function test were available in 8,613 subjects.
Initial data were obtained from the 8,613 subjects aged 
40–69 years who participated in Ansung–Ansan cohort I 
(2001–2002) and have valid lung function measurements. 
Follow-up examinations were conducted biennially. Data 
from a baseline survey and two subsequent biennial sur-
veys (I–III: 2001–2006) were analyzed in our study. Of the 
8,613 subjects in the study, 6,517 who underwent pulmonary 
function testing two or more times during I–III were included 
in this study (Figure 1).
The Korea Centers for Disease Control and Prevention 
obtained written informed consent from all participants, 
and the Institutional Review Board of Severance Hospital 
approved this study protocol (4-2016-0458).
spirometry
Lung function was measured by spirometry (VMAX2130, 
SensorMedics Corporation, Yorba, CA, USA) at every visit 
(at baseline and at the first and second follow-up visits). 
COPD was defined as a pre-bronchodilator FEV
1
/FVC 
ratio ,0.7.
statistical analysis
COPD is a progressive disease, and we assumed that subjects 
were affected if they were diagnosed with COPD at least once 
during follow-up. Lung function was measured in all sub-
jects up to three times, and if subjects who had been healthy 
at the previous visit became affected at the next visit, they 
were assumed to be affected at the mid time point between 
these two visits. On the basis of these definitions, we cal-
culated crude, age-specific, and sex-specific incidence rates 
Figure 1 Flowchart of patient selection for the study.
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per 100,000 person-years (PY); CIs of incidence rates were 
obtained under the assumption that the number of events fol-
lows the Poisson distribution. Age-specific and sex-specific 
incidence rates were summed to obtain the standardized 
Korean incidence rates by weighting them with their propor-
tions in the Korean general population.
Furthermore, we calculated relative risks (RRs) by using 
log-binomial regression.17 Response variables were assumed 
to follow a binomial distribution, and a logarithm was used 
as a link function. We included age, sex, smoking history, 
and income as covariates, and our generalized linear model 
for subject i was
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The estimated exp(β ) indicates the RRs when the corre-
sponding covariate increases by 1 unit and the other covari-
ates are the same.
Finally, we estimated attributable risks (ARs) with RRs. 
We assumed that there are k different groups and that the RR 
in each group j is R J. If we denote the proportion of cases in 
group j compared with all cases by ρ
j
, the adjusted ARs can 
be estimated by AR =1−
j
j
JR
ρ

∑ .18
Results
Baseline characteristics
Of the 8,613 subjects, 761 (8.8%) had prevalent COPD at 
baseline, and 329 of the 6,517 at-risk subjects developed 
COPD during the follow-up period. The median follow-up 
duration was 4 years (interquartile range 3.0–4.0 years). 
Table 1 shows the baseline characteristics of the study 
population. Half of the subjects were aged 40–49 years, and 
46.0% were men.
Incidence rate of COPD
During follow-up, 329 new cases of COPD were diag-
nosed. The overall crude incidence of COPD in persons 
aged $40 years was 1,447/100,000 PY (Table 2). The 
incidence of COPD was higher in men than in women 
(2,541/100,000 PY vs 564/100,000 PY, respectively). The 
incidence rate increased almost fourfold from 713/100,000 
PY at the age of 40–49 years to 2,888/100,000 PY at the age 
of 60–69 years (Table 2, Figure 2A). The overall standardized 
incidence rate corrected for the Korean general population 
was 1,550/100,000 PY. The standardized incidence rate for 
COPD was higher in men than in women and increased with 
increasing age (Table 3; Figure 2B).
risk factors for incident COPD
Table 4 shows the risk factors for incident COPD. After 
adjusting for other variables, the risk factors for incident 
COPD were age $60 years (adjusted RR 2.52; 95% CI 
2.23–2.85), male sex (adjusted RR 2.02; 95% CI 1.64–2.48), 
heavy smoking ($20 pack-years; adjusted RR 2.54; 95% CI 
2.09–3.08), and lowest income group (first quartile; adjusted 
RR 2.03; 95% CI 1.64–2.50). Table S1 demonstrates the risk 
factors for incident COPD including smoking history of never, 
former, and current smokers. The adjusted RRs were 1.90 
(95% CI 1.55–2.33) for the former smokers and 2.48 (95% 
CI 2.05–2.99) for the current smokers. Table 5 shows the 
adjusted AR for incident COPD. When adjusted for the risk 
Table 1 Baseline characteristics of the study population stratified 
according to age, sex, smoking status, and income
Characteristics Total Male Female
n (%) n (%) n (%)
age (n=6,517)
40–49 3,334 (51.2) 1,686 (56.2) 1,648 (46.8)
50–59 1,733 (26.6) 775 (25.9) 958 (27.2)
60–69 1,450 (22.2) 536 (17.9) 914 (26.0)
sex (n=6,517)
Male 2,997 (46.0) – –
Female 3,520 (54.0) – –
smoking history (n=6,517)
never smokers 4,018 (61.7) 643 (21.5) 3,375 (95.9)
Former smokers 1,005 (15.4) 965 (32.2) 40 (1.1)
Current smokers 1,494 (22.9) 1,389 (46.3) 105 (3.0)
Income (n=6,514)
First quartile 2,064 (31.6) 657 (21.9) 1,409 (40.0)
second quartile 1,941 (29.8) 928 (31.0) 1,013 (28.8)
Third quartile 1,972 (30.2) 1,087 (36.3) 886 (25.2)
Fourth quartile 537 (8.2) 325 (10.8) 212 (6.0)
education (n=6,485)
elementary school or lower 1,963 (30.3) 464 (15.5) 1,499 (42.9)
Middle school 1,440 (22.2) 611 (20.5) 829 (23.7)
high school 2,118 (32.7) 1,168 (39.1) 950 (27.1)
College/university or higher 964 (14.9) 744 (24.9) 220 (6.3)
Table 2 Overall, age-specific, and sex-specific crude incidence 
rates of COPD per 100,000 person-years
Age groups, 
years
Overall, 
COPD IR
Men, 
COPD IR
Women, 
COPD IR
40–49 713.9 1,104.5 332.9
50–59 1,288.4 2,430.3 327.3
60–69 2,888.5 6,137.6 1,105.3
all age categories 1,447.8 2,541.6 564.7
Abbreviation: Ir, incidence rate.
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factors, the AR for education level of high school or lower 
predominated (adjusted AR 44.9%), followed by smoking his-
tory (adjusted AR 25.8%), income in the first to third quartiles 
(adjusted AR 22.9%), and male sex (adjusted AR 12.0%).
Discussion
In our study, the overall crude incidence rate of COPD 
was 1,447/100,000 PY and the standardized incidence 
rate corrected for the Korean general population was 
1,550/100,000 PY. The incidence increased with older age, 
heavier smoking, lower income, and male sex. After adjust-
ment for the other three variables, the AR for smoking his-
tory was the highest, followed by low income, older age, 
and male sex.
Previous epidemiologic studies of COPD were mainly 
focused on the prevalence of COPD because they often 
applied a cross-sectional spirometry-based approach to 
obtain the true prevalence of COPD. In the present study, 
the prevalence of COPD at baseline was found to be 8.8%, 
which is lower than that reported previously for Korea.19 The 
subjects in the present study were aged 40–69 years, whereas 
the previous study included subjects aged $45 years, with 
20% of the subjects aged .65 years.
Several studies have reported the incidence of COPD in 
various populations and countries using different diagnostic 
methods, including spirometry and healthcare databases 
(Table 6).7–9,11,20–27 In a Swedish report based on the Obstruc-
tive Lung Disease in Northern Sweden cohort, Lindberg 
et al estimated the incidence rate of COPD at 13.1/1,000 PY 
according to the Global Initiative for Chronic Obstruc-
tive Lung Disease (GOLD) spirometric criteria (FEV
1
/
FVC ,0.7).7 In that study, a random sample of 963 subjects 
aged 46–77 years were invited for a structured interview 
and spirometry.7 The findings of Lindberg et al are similar 
to ours, which may be because of the similar age categories 
and spirometry-based criteria for COPD used in the two stud-
ies. In a study by de Marco et al the incidence rate of COPD 
was found to be 2.8/1,000 PY in an international cohort of 
5,002 subjects aged 20–44 years.20 The lower incidence 
rate in their study when compared with that in ours may be 
explained by the younger age of their study population. In a 
study performed by van Durme et al in the Netherlands, the 
incidence of COPD was evaluated in a large prospective 
population-based cohort of 7,983 subjects aged $55 years.8 
Their study was part of the Rotterdam Study, an ongoing 
population-based cohort study that is assessing the occur-
rence of and risk factors for chronic diseases in the elderly. 
COPD was diagnosed using an algorithm based on validation 
of hospital discharge letters, files from the general practitio-
ner, and spirometry reports. Only 44.5% (3,550/7,983) of 
Figure 2 Age-specific and sex-specific (A) incidence rates of COPD per 100,000 person-years, and (B) standardized incidence rates of COPD per 100,000 person-years 
(standardized for the Korean general population).
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Table 3 Overall, age-specific, and sex-specific standardized incidence rates of COPD per 100,000 person-years (standardized for the 
Korean general population)
Age groups, 
years
Overall Men Women
COPD IR 95% CI COPD IR 95% CI COPD IR 95% CI
40–49 684.8 523.8–845.9 1,033.6 755.5–1,311.7 341.6 176.4–506.8
50–59 1,263.0 999.0–1,527.0 2,412.0 1,873.4–2,950.7 311.2 134.9–487.5
60–69 3,165.4 2,628.5–3,702.3 6,933.1 5,624.5–8,241.7 1,104.1 724.0–1,484.3
all age categories 1,550.0 1,368.2–1,731.8 3,007.8 2,609.7–3,405.9 551.6 412.4–690.8
Abbreviation: Ir, incidence rate.
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participants underwent spirometry. In the absence of spirom-
etry, the investigators reviewed all medical information for 
subjects who had used respiratory medication for at least 
6 months and all hospital discharge letters or mortality reports 
with a coded diagnosis of COPD. The overall incidence rate 
was 9.2/1,000 PY, which is much lower than that in our study, 
although their study was conducted in an elderly population. 
Detection of COPD on the basis of medical records and 
healthcare utilization may have resulted in an underestima-
tion of COPD incidence. Respiratory symptoms are often 
absent in patients with early COPD, and not all patients with 
respiratory symptoms seek medical services because of low 
public awareness of COPD.28 Therefore, the incidence of 
physician-diagnosed (coded diagnosis) COPD can be lower 
than the incidence of COPD defined by spirometry.8,29
In our study, we used spirometry as a screening tool for 
the detection of COPD in all subjects. Therefore, we could 
detect asymptomatic patients with COPD, resulting in a 
higher but more accurate incidence rate than that in other 
studies. In a study by Kojima et al in Japan, the incidence 
rates per 1,000 PY were 8.1 in men and 3.1 in women.11 
In this study, participants were aged 25–74 years at the time 
of health check-ups, including spirometry, at a single regional 
medical center. Differences in the study populations may be 
the reason why the incidence rates in Korea and Japan are 
different, even though the follow-up duration was similar. 
Moreover, high rate of smoking, especially in male Korean 
adults (62% in 2000 and 52% in 2012, decreasing down to 
43.1% in 2014), is attributable to the relatively high inci-
dence rate of COPD in Korea compared with that in most 
European countries.30,31
In the present study, we confirmed known risk factors for 
COPD, including smoking history, male sex, and increasing 
age. Cigarette smoking is a widely proven risk factor for 
COPD. The proportion of smokers in COPD patients is 
two-thirds, while age, sex, exposure to particles including 
organic and inorganic dusts, socioeconomic status, and 
bronchial hyperreactivity have been regarded as possible 
risk factors for COPD.1 However, limited longitudinal data 
are available on other risk factors and RRs associated with 
COPD development.6–9,25 In the Swedish study by Lindberg 
et al, incident COPD according to the GOLD criteria (FEV
1
/
FVC ,0.7) was significantly associated with increasing age 
and the smoking status of current smokers, but not with sex 
in a general population sample.7 In the study by van Durme 
et al, male sex and smoking status of current smokers were 
related to occurrence of COPD.8 In a study by Afonso et al in 
Table 4 risk factors and adjusted relative risk of incident COPDa
Risk factors Total Male Female
Adjusted 
relative riska
95% CI Adjusted 
relative riska
95% CI Adjusted 
relative riska
95% CI
age
,60 years reference reference reference
$60 years 2.52 2.23–2.85 2.60 2.26–2.98 2.18 1.68–2.84
sex
Female reference – – – –
Male 2.02 1.64–2.48 – – – –
smoking history
never smoker reference reference reference
1–19 pack-years 1.78 1.44–2.20 1.58 1.25–1.99 2.66 1.77–3.99
$20 pack-years 2.54 2.09–3.08 2.30 1.88–2.81 3.94 2.12–7.31
Income
Fourth quartile reference reference reference
Third quartile 1.29 1.01–1.65 1.14 0.87–1.49 2.48 1.27–4.86
second quartile 1.56 1.26–1.93 1.48 1.18–1.86 2.18 1.15–4.15
First quartile 2.03 1.64–2.50 1.89 1.51–2.37 2.99 1.61–5.57
Note: aadjusted for other factors (age, sex, smoking history, and income).
Table 5 adjusted attributable risk of incident COPD
Risk factors Total Male Female
Adjusted 
attributable 
riska
Adjusted 
attributable 
riskb
Adjusted 
attributable 
riskb
sex, male 0.120 – –
ever-smokers 0.258 0.244 0.365
Income of first 
to third quartiles
0.229 0.208 0.323
education of high 
school or lower
0.449 0.458 0.393
Notes: aadjusted for other factors (sex, smoking status, income, and education 
level). badjusted for other factors (smoking status, income, and education level).
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the Netherlands, male sex, increasing age, and smoking his-
tory were strong risk factors for COPD, and these associations 
remained significant after adjustment for other variables.9 
In our study, increasing age, heavier smoking, lower income, 
and male sex were risk factors for incident COPD. This is 
the first study to identify income as a risk factor for incident 
COPD. Furthermore, no previous reports exist on the AR of 
each risk factor for incident COPD. In our study, the adjusted 
AR was highest for low education level of high school or 
lower, followed by smoking history, low income, and male 
sex. Low income included the first to third quartiles, sug-
gesting that subjects with an intermediate income are also 
at high risk of COPD.
The strengths of this study are its prospective population-
based design, large cohort size, and the use of spirometric 
results for all cohort participants. However, the study also 
has several limitations. First, the follow-up period was 
relatively short. Because half of the subjects were aged 
40–49 years, their age was ,55 years even after a median 
follow-up duration of 4 years. However, the Ansung–Ansan 
cohort study is ongoing, and we expect to be able to analyze 
the data further with longer follow-up. Second, we used 
pre-bronchodilator spirometric values instead of post-
bronchodilator values to define COPD. However, previous 
study reported that the assessment of prognostic risk factors 
for COPD was not influenced by the type of lung func-
tion assessment (before or after bronchodilation), even if 
the prevalence of COPD defined without bronchodilation 
may be overestimated.32 Third, information on mortality 
of subjects was not available. Further study is warranted to 
investigate mortality rates and mortality-related factors in a 
longitudinal cohort of Koreans with COPD. Lastly, the data 
on smoking cessation have not been confirmed objectively 
using biological method.
In conclusion, in the Korean general population, around 
15.5/1,000 individuals are newly diagnosed with COPD 
every year. The incidence rate increases with increasing age, 
increasing amount of smoking, and decreasing income and 
is higher in men than in women.
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Supplementary material
Table S1 risk factors and adjusted relative risk of incident COPDa
Risk factors Total Male Female
Adjusted 
relative riska
95% CI Adjusted 
relative riska
95% CI Adjusted 
relative riska
95% CI
age
,60 years reference reference reference reference reference reference
$60 years 2.66 2.35–3.01 2.78 2.42–3.2 2.21 1.69–2.89
sex
Female reference reference – – – –
Male 2.15 1.76–2.63 – – – –
smoking history
never smokers reference reference reference reference reference reference
Former smokers 1.90 1.55–2.33 1.79 1.44–2.23 1.02 0.34–3.01
Current smokers 2.48 2.05–2.99 2.28 1.86–2.80 4.04 2.84–5.75
Income
Fourth quartile reference reference reference reference reference reference
Third quartile 1.27 0.99–1.62 1.14 0.87–1.49 2.29 1.16–4.53
second quartile 1.56 1.26–1.93 1.48 1.18–1.86 2.19 1.15–4.15
First quartile 2.03 1.64–2.5 1.91 1.52–2.39 2.90 1.56–5.42
Note: aadjusted for other factors (age, sex, smoking history, and income).
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